Aquaporin-1-mediated cerebral edema following traumatic brain injury: effects of acidosis and corticosteroid administration

J Neurosurg. 2010 May;112(5):1095-104. doi: 10.3171/2009.8.JNS081704.

Abstract

Object: Dysregulation of water homeostasis induces cerebral edema. Edema is a major cause of morbidity and mortality following traumatic brain injury (TBI). Aquaporin-1 (AQP-1), a water channel found in the brain, can function as a transporter for CO2 across the cellular membrane. Additionally, AQP-1's promoter contains a glucocorticoid response element. Thus, AQP-1 may be involved with edema-related brain injury and might be modulated by external conditions such as the pH and the presence of steroids. In this study, the authors investigated the hypotheses that: 1) AQP-1 participates in brain water homeostasis following TBI; 2) secondary injury (for example, acidosis) alters the expression of AQP-1 and exacerbates cerebral edema; and 3) corticosteroids augment brain AQP-1 expression and differentially affect cerebral edema under nonacidotic and acidotic conditions.

Methods: Anesthetized Sprague-Dawley rats were subjected to moderate to severe TBI (2.5-3.5 atm) or surgery without injury, and they were randomized to receive a 3-mg/kg bolus of intravenous dexamethasone within 10 minutes after injury or surgery, a 3-mg/kg bolus of dexamethasone followed by 1-mg/kg maintenance doses every 8 hours for 24 hours, or saline boluses at similar time intervals. A second group of animals was subjected to respiratory acidosis with target arterial blood pH 6.8-7.2 for 1 hour following the surgery or injury. To evaluate selective blockage of AQP-1, some animals received a single intraperitoneal dose of HgCl2 (0.3-30.0 mmol/L) within 30 minutes of injury or surgery. At 4 or 24 hours postinjury, animals were killed and their brains were harvested for mRNA, protein, or water content analyses.

Results: The authors demonstrated elevated cerebral edema levels at 4 and 24 hours following TBI. Dexamethasone administration within 1 hour of TBI attenuated the cerebral edema under nonacidotic conditions but worsened it under acidotic conditions. Selective blockage of AQP-1 channels with HgCl2 attenuated the edematous effects of corticosteroids and acidosis. Reverse transcriptase polymerase chain reaction and immunohistochemical analyses demonstrated a paucity of AQP-1 in the cerebral cortices of the uninjured animals. In contrast, AQP-1 mRNA and protein levels were higher in the cerebral cortices of animals that sustained a TBI.

Conclusions: These findings implicate an important, modifiable role for AQP-1 in water homeostasis within the CNS following TBI.

Publication types

  • Evaluation Study

MeSH terms

  • Acidosis / diagnosis*
  • Acidosis / etiology*
  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Aquaporin 1 / genetics*
  • Blotting, Western
  • Brain Edema* / drug therapy
  • Brain Edema* / etiology
  • Brain Edema* / genetics
  • Brain Injuries / complications*
  • DNA Primers / genetics
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use*
  • Immunoblotting
  • Immunohistochemistry
  • Infusions, Intravenous
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Anti-Inflammatory Agents
  • DNA Primers
  • Aquaporin 1
  • Dexamethasone